Medicare Enrolled

Dr. Marketa Limova, M.D.

Dermatology · Fresno, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
1340 W HERNDON AVE STE 101, Fresno, CA 93711
5594386577
Registered in NPPES since 2006
NPI: 1871660936 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Limova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Limova? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Limova

Dr. Marketa Limova is a dermatology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Limova performed 6,902 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Limova received a total of $23,719 from 50 pharmaceutical and/or device companies across 732 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Limova is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 16% volume in CA $23,719 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
6,902
Medicare services
Top 16% in CA for dermatology
Not available
Unique patients (not deduplicated)
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
1,267 $58 $125
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
1,135 $93 $159
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
1,124 $126 $206
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
666 $67 $117
High dose rate electronic brachytherapy, external 351 $129 $220
External heat therapy for cancer cells, 4 cm depth or less
This procedure uses externally generated heat to raise the temperature of cancer cells to a depth of 4.0 cm or less.
300 $439 $636
Topical aminolevulinic acid HCl 20% solution
A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient.
288 $301 $466
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
245 $77 $125
Radiation treatment planning, 1 area
This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area.
241 $222 $325
Light application with debridement to destroy precancerous skin growth
This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths.
237 $208 $400
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
217 $6 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
144 $99 $142
Fluorouracil injection, 500 mg
Administration of a 500 mg dose of fluorouracil medication via injection.
57 $2 $25
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
55 $41 $95
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
52 $40 $70
Surgical removal of skin cancer, 2.1-3.0 cm
This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters.
51 $113 $340
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
50 $12 $40
Chemotherapy administration, 1-7 injections
This procedure involves the administration of chemotherapy medication through one to seven separate injections.
45 $64 $130
Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm
A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length.
43 $330 $505
Complicated wound repair of trunk, 2.6-7.5 cm
A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length.
29 $310 $470
Ear tissue biopsy
A procedure to remove a small sample of tissue from the ear for laboratory examination.
29 $64 $145
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
29 $33 $75
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
27 $1 $10
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
23 $87 $140
Destruction of cancerous skin growth on face, 1.1-2.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter.
22 $149 $245
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
20 $106 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $126 $210
Skin graft repair, 10 sq cm or less
A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts.
18 $613 $890
Eyelid biopsy
A procedure to remove a small sample of tissue from the eyelid for laboratory examination.
18 $147 $230
Tuberculosis skin test
A small amount of fluid is injected under the skin to check for a reaction that indicates exposure to tuberculosis bacteria.
18 $7 $25
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
16 $130 $210
Intermediate wound repair, 2.5 cm or less
This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing.
15 $221 $296
Complicated wound repair, 2.6-7.5 cm
A complex surgical procedure to close a wound measuring between 2.6 and 7.5 centimeters on areas such as the face, neck, hands, or feet.
14 $391 $566
Removal of noncancer skin growth, 0.6-1.0 cm
This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter.
13 $65 $180
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 13 $140 $225
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $46 $70
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,719
Total received (2018-2024)
Avg $3,388/year across 7 years
Top 9% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
732
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,779
2023
$3,108
2022
$2,443
2021
$2,365
2020
$1,709
2019
$2,987
2018
$8,328

Payments by company (2024)

ABBVIE INC.
$579
Incyte Corporation
$474
SUN PHARMACEUTICAL INDUSTRIES INC.
$258
PFIZER INC.
$244
Regeneron Healthcare Solutions, Inc.
$200
UCB, Inc.
$167
Janssen Biotech, Inc.
$155
LEO Pharma Inc.
$153
Arcutis Biotherapeutics, Inc.
$142
E.R. Squibb & Sons, L.L.C.
$113
Lilly USA, LLC
$82
Galderma Laboratories, L.P.
$38
REVANCE THERAPEUTICS, INC.
$33
STRATA Skin Sciences, Inc.
$31
Organogenesis Inc.
$28
Amgen Inc.
$28
Biofrontera Inc.
$27
Dermavant Sciences, Inc.
$26
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$5,906
ABBVIE INC.
$2,206
Incyte Corporation
$1,608
Sun Pharmaceutical Industries Inc.
$1,315
Novartis Pharmaceuticals Corporation
$1,140
Lilly USA, LLC
$951
PFIZER INC.
$884
Merz North America, Inc.
$826
Ortho Dermatologics, a division of Bausch Health US, LLC
$662
AbbVie, Inc.
$643
LEO Pharma Inc.
$643
AbbVie Inc.
$640
Celgene Corporation
$609
Regeneron Healthcare Solutions, Inc.
$584
SUN PHARMACEUTICAL INDUSTRIES INC.
$519
UCB, Inc.
$518
Amgen Inc.
$477
E.R. Squibb & Sons, L.L.C.
$447
STRATA Skin Sciences, Inc.
$364
Galderma Laboratories, L.P.
$298
VYNE Pharmaceuticals Inc.
$278
Mayne Pharma Inc.
$278
MERZ NORTH AMERICA, INC.
$219
EPI Health, LLC
$209
GENZYME CORPORATION
$160
Arcutis Biotherapeutics, Inc.
$142
Biofrontera Inc.
$133
Aclaris Therapeutics, Inc.
$132
Stemline Therapeutics Inc.
$130
DUSA Pharmaceuticals, Inc.
$118
Dermavant Sciences, Inc.
$97
Genentech USA, Inc.
$89
Almirall LLC
$50
ORGANOGENESIS INC.
$43
Janssen Scientific Affairs, LLC
$40
Promius Pharma LLC
$39
Nabriva Therapeutics, plc
$38
REVANCE THERAPEUTICS, INC.
$33
Fresenius Kabi USA, LLC
$31
Organogenesis Inc.
$28
Allergan Inc.
$26
Helsinn Therapeutics (U.S.), Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
DERMIRA, INC.
$23
GlaxoSmithKline, LLC.
$19
Solta Medical, a division of Bausch Health US, LLC
$18
Alfasigma USA, Inc.
$18
Merck Sharp & Dohme Corporation
$16
Mylan Pharmaceuticals Inc.
$14
NOVARTIS PHARMACEUTICALS CORPORATION
$12
Top 3 companies account for 41.0% of all-time payments
Associated products mentioned in payments ›
20% · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · DAXXIFY · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · HUMIRA · Humira · ICLUSIG · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · LEVULAN KERASTICK · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ODOMZO · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · PURAPLY AM · Promiseb Complete · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SHINGRIX · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Sernivo · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VALCHLOR · VTAMA · WYNZORA · Winlevi · XELJANZ · XEOMIN · XTRAC · Xeomin · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Fresno?
Compare dermatologists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
27
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
FRESNO SURGICAL HOSPITAL
4.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Limova is a mixed practice specialist, with above-average Medicare volume (top 16% in CA), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Limova experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Limova performed 1,267 tissue pathology examination, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Limova receive payments from pharmaceutical companies?
Yes. Dr. Limova received a total of $23,719 from 50 companies across 732 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Limova's costs compare to other dermatologists in Fresno?
Dr. Limova's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Limova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →